# ENDRA Life Sciences Inc. (NDRA)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/NDRA/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -1.15M | $ -2.07M | $ 429.3K | $ 6.31M |
| 2025 | $ 0 | $ -7.20M | $ -8.40M | $ 492.4K | $ 2.26M |
| 2024 | $ 0 | $ -12.10M | $ -7.80M | $ 754.1K | $ 2.56M |
| 2023 | $ 0 | $ -10.88M | $ -10.36M | $ 394.4K | $ 5.66M |
| 2022 | $ 0 | $ -14.72M | $ -14.49M | $ 546.6K | $ 7.20M |
| 2021 | $ 0 | $ -13.35M | $ -13.27M | $ 796.1K | $ 10.78M |
| 2020 | $ 0 | $ -14.94M | $ -13.82M | $ 769.3K | $ 7.17M |
| 2019 | $ 0 | $ -17.17M | $ -11.14M | $ 731.0K | $ 4.76M |
| 2018 | $ 8.2K | $ -12.94M | $ -10.44M | $ 22 | $ 6.25M |
| 2017 | $ 473.7K | $ -7.24M | $ -4.46M | $ 0 | $ 5.28M |
| 2016 | $ 709.4K | $ -3.82M | $ -1.81M | $ 950.0K | $ -893.8K |
| 2015 | $ 2.11M | $ -3.38M | $ 44.4K | $ 0 | $ 250.3K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.07 |
| Liabilities / Eq | 0.26 |
| Current Ratio | 7.10 |

## Other views

- [Metrics](https://sponda.capital/en/NDRA.md)
- [Charts](https://sponda.capital/en/NDRA/charts.md)
- [Compare](https://sponda.capital/en/NDRA/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.